Monday, December 04, 2006
Doctors Divided Over Loss of Experimental Cholesterol Drug - Forbes
¶ 5:09 PM 
 Earthtimes.org | Doctors Divided Over Loss of Experimental Cholesterol Drug Forbes - MONDAY Dec. 4 (HealthDay News) -- While some heart experts are calling Pfizer Inc. (nyse: PFE - news - people )'s decision to halt development of a promising new cholesterol drug a major disappointment other ... Pfizer Shares Tumbling On Halted Test Heart disease drug trial stopped amid death fears |
RSS :
